Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR

Delayed Quote. Delayed  - 02/12 03:59:58 pm
33.63 USD   +0.45%
02/11 ACORDA THERAPEU : misses 4Q profit forecasts
02/11 ACORDA THERAPEU : Provides Financial and Pipeline Update for Fourth ..
02/04 ACORDA THERAPEU : to Present at Two Investor Conferences in February
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/08/2016 02/09/2016 02/10/2016 02/11/2016 02/12/2016 Date
35.58(c) 35.35(c) 36.22(c) 33.48(c) 33.62(c) Last
572 646 813 643 1 084 923 1 101 752 918 838 Volume
-2.97% -0.65% +2.46% -7.56% +0.42% Change
More quotes
Financials ($)
Sales 2016 518 M
EBIT 2016 17,5 M
Net income 2016 -2,82 M
Debt 2016 -
Yield 2016 -
Sales 2017 559 M
EBIT 2017 21,3 M
Net income 2017 -0,25 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017 759,14
Capi. / Sales 2016 2,80x
Capi. / Sales 2017 2,59x
Capitalization 1 451 M
More Financials
Company
Acorda Therapeutics, Inc. develops and markets therapeutic products for nervous system disorders.The company's two main products are Ampyra and Zanaflex Capsules.The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short... 
Sector
Biotechnology & Medical Research
Calendar
02/23 | 03:05pmPresentation
More about the company
Surperformance© ratings of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ACORDA THERAPEUTICS INC
02/11 ACORDA THERAPEUTICS : Results of Operations and Financial Condition, Financial S..
02/11 ACORDA THERAPEUTICS : misses 4Q profit forecasts
02/11 ACORDA THERAPEUTICS : Provides Financial and Pipeline Update for Fourth Quarter ..
02/04 ACORDA THERAPEUTICS : to Present at Two Investor Conferences in February
01/28 ACORDA THERAPEUTICS : to Host Conference Call to Discuss Fourth Quarter and Year..
01/25 ACORDA THERAPEUTICS : Unregistered Sale of Equity Securities (form 8-K)
01/21 ACORDA THERAPEUTICS : Reports Summarize Multiple Sclerosis Findings from Acorda ..
01/21 ACORDA THERAPEUTICS : Announces 2015 AMPYRA Sales, 2016 Financial Guidance and 2..
More news
Sector news : Bio Therapeutic Drugs
02/13 LONZA : Pease Lonza may add up to 400 jobs Firm requests city cut building permi..
02/12 AMGEN : Mystery cannabis 'consortium' reportedly interested in Longmont's Amgen ..
02/12 AMGEN : Kyprolis launches in the UK for relapsed multiple myeloma
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
02/11 Acorda Therapeutics' (ACOR) CEO Ron Cohen on Q4 2015 Results - Earnings Call ..
02/11 Acorda Therapeutics reports Q4 and FY15 results
02/11 Acorda Therapeutics (ACOR) Q4 2015 Results - Earnings Call Webcast
02/11 Acorda Therapeutics beats by $0.06, beats on revenue
02/10 Notable earnings before Thursday?s open


Comments 
Advertisement
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Technical analysis trends ACORDA THERAPEUTI...
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions